Peter Stephens
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Pharmaceutical Economics and Policy 7
- Health Systems, Economic Evaluations, Quality of Life 3
- History 3
- Reformation and Early Modern Christianity 3
- Co-authors
- Lucinda M. C. Hall (1 shared paper)Virve I. Enne (1 shared paper)David M. Livermore (1 shared paper)Veronika J. Wirtz (3 shared papers)Dennis Ross‐Degnan (9 shared papers)Hans V. Hogerzeil (2 shared papers)Margaret Ewen (2 shared papers)Anita K. Wagner (2 shared papers)
- Journals
- Journal of Pharmaceutical Policy and Practice (2 papers)The Lancet (2 papers)Health Policy (1 paper)PLoS ONE (1 paper)BMJ Open (1 paper)
- Partner nations
- United StatesNetherlandsUnited Kingdom
In The Last Decade
Peter Stephens
22 papers receiving 969 citations
Peter Stephens's Hit Papers
Peers
Comparison fields: 5 of 118
- Applied Microbiology and Biotechnology 138
- Molecular Medicine 245
- Pollution 154
- Endocrinology 53
- Economics and Econometrics 258
Countries citing papers authored by Peter Stephens
This map shows the geographic impact of Peter Stephens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Stephens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Stephens more than expected).
Fields of papers citing papers by Peter Stephens
This network shows the impact of papers produced by Peter Stephens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Stephens. The network helps show where Peter Stephens may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Stephens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 410 | |
| 2 | Essential medicines for universal health coverage Hit paper breakdown → | 2016 | 376 |
| 3 | 2019 | 56 | |
| 4 | 2013 | 45 | |
| 5 | 2012 | 22 | |
| 6 | The East Asian economic miracle | 1994 | 21 |
| 7 | 2013 | 14 | |
| 8 | 2002 | 12 | |
| 9 | 2014 | 11 | |
| 10 | 2015 | 8 | |
| 11 | 2014 | 8 | |
| 12 | 2020 | 7 | |
| 13 | 2019 | 6 | |
| 14 | 2013 | 6 | |
| 15 | 2018 | 5 | |
| 16 | 2019 | 5 | |
| 17 | 2004 | 3 | |
| 18 | 2018 | 3 | |
| 19 | 2014 | 1 | |
| 20 | The Sacraments in the Confessions of 1536, 1549, and 1566: Bullinger's Understanding in the Light of Zwingli's | 2006 | 1 |
About Peter Stephens
Peter Stephens is a scholar working on Economics and Econometrics, History, Pediatrics, Perinatology and Child Health, Sociology and Political Science and Finance, having authored 23 papers that have together received 1.0k indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (7 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers), Reformation and Early Modern Christianity (3 papers), Healthcare Systems and Reforms (2 papers), Historical and Linguistic Studies (2 papers), Pharmaceutical studies and practices (2 papers), Intellectual Property and Patents (1 paper) and Medieval Literature and History (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (138 citations), Molecular Medicine (245 citations), Pollution (154 citations), Endocrinology (53 citations) and Economics and Econometrics (258 citations). Peter Stephens has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Lucinda M. C. Hall, Virve I. Enne, David M. Livermore, Veronika J. Wirtz, Dennis Ross‐Degnan, Hans V. Hogerzeil, Margaret Ewen, Anita K. Wagner, Prashant Yadav and Bernard Pécoul. Their work appears in journals such as Journal of Pharmaceutical Policy and Practice, The Lancet, Health Policy, PLoS ONE and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.